Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 09-1994 | 06-1994 | 03-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,050 | 1,880 | 1,710 | 1,390 | 900 |
| TOTAL | $1,050 | $1,880 | $1,710 | $1,390 | $900 |
| Non-Current Assets | |||||
| Investments And Advances | 3,510 | 3,540 | 6,470 | 6,820 | 0 |
| Other Non-Current Assets | 14,130 | 14,430 | 22,140 | 21,060 | 20,300 |
| TOTAL | $17,640 | $17,970 | $28,610 | $27,880 | $20,300 |
| Total Assets | $18,690 | $19,850 | $30,320 | $29,270 | $21,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 500 | 510 | 530 | N/A |
| Accounts payable and accrued liabilities | 1,720 | 0 | 0 | 0 | 2,100 |
| Accrued Expenses | 10,500 | N/A | N/A | N/A | 7,220 |
| Other current liabilities | 15,340 | 15,820 | 15,290 | 15,770 | 16,070 |
| TOTAL | $27,560 | $16,320 | $15,800 | $16,300 | $25,960 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,850 | 1,660 | 1,720 | 1,790 | 1,800 |
| TOTAL | $1,850 | $1,660 | $1,720 | $1,790 | $2,470 |
| Total Liabilities | $29,410 | $17,980 | $17,520 | $18,090 | $28,430 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Other shareholders' equity | 30 | 30 | 70 | 110 | 130 |
| TOTAL | $67,000 | $66,710 | $66,680 | $65,880 | $65,870 |
| Total Liabilities And Equity | $96,410 | $84,690 | $84,200 | $83,970 | $94,300 |